PLx Pharma Winddown Corp. Quarterly Debt-to-equity in % from Q1 2016 to Q3 2022

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
PLx Pharma Winddown Corp. quarterly Debt-to-equity history and growth rate from Q1 2016 to Q3 2022.
  • PLx Pharma Winddown Corp. Debt-to-equity for the quarter ending September 30, 2022 was 71.2 %, a 33.7% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2022 71.2 -36.2 -33.7% Sep 30, 2022
Q2 2022 92.5 -54.1 -36.9% Jun 30, 2022
Q1 2022 88.9 +2.74K Mar 31, 2022
Q4 2021 80.2 +169 Dec 31, 2021
Q3 2021 107 +196 Sep 30, 2021
Q2 2021 147 +268 Jun 30, 2021
Q1 2021 -2.65K -2.49K -1590% Mar 31, 2021
Q4 2020 -88.9 +115 +56.3% Dec 31, 2020
Q3 2020 -88.5 +267 +75.1% Sep 30, 2020
Q2 2020 -121 +814 +87% Jun 30, 2020
Q1 2020 -157 -703 -129% Mar 31, 2020
Q4 2019 -204 -435 -188% Dec 31, 2019
Q3 2019 -355 -655 -219% Sep 30, 2019
Q2 2019 -936 -1.18K -487% Jun 30, 2019
Q1 2019 546 +350 +179% Mar 31, 2019
Q4 2018 232 +86.4 +59.5% Dec 31, 2018
Q3 2018 299 +183 +157% Sep 30, 2018
Q2 2018 242 +194 +405% Jun 30, 2018
Q1 2018 196 +186 +1842% Mar 31, 2018
Q4 2017 145 +136 +1554% Dec 31, 2017
Q3 2017 116 +110 +1698% Sep 30, 2017
Q2 2017 47.8 +42.8 +851% Jun 30, 2017
Q1 2017 10.1 +5.73 +131% Mar 31, 2017
Q4 2016 8.78 Dec 31, 2016
Q3 2016 6.47 Sep 30, 2016
Q2 2016 5.03 Jun 30, 2016
Q1 2016 4.36 Mar 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.